As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

As 2026 commences, global health authorities are enforcing a transition from siloed electronic records to a unified longitudinal patient view. This evolution is driven by the recent World Health Assembly resolution aimed at eliminating data fragmentation that currently hinders emergency response and chronic care management. With the integration of advanced semantic layers, clinicians in major...

The Pulse Oximeters Market is rapidly advancing with AI-enabled health monitoring solutions. Modern devices track oxygen saturation in real-time, offering predictive insights and alerting users to potential health risks. AI-powered pulse oximeters not only enhance accuracy but also support integration with digital health platforms, making them vital for hospitals, clinics, and home healthcare....